Answers are grounded in this paper and cite their sources.
The P2Y 12 receptor (P2Y 12 R) is a G-protein-coupled receptor whose expression level is directly correlated to microglial activation. Herein, we report on the design of a series of new P2Y 12 R ligands and the radiolabeling and characterization of two positron emission tomography (PET) tracers, [ 11 C] 37 and [ 18 F] 41 . These compounds were evaluated by autoradiography studies on rat brain slices exhibiting overexpression of human P2Y 12 Rs (AAV- h P2Y 12 R). Metabolism and biodistribution of [ 18 F] 41 were evaluated ex vivo in healthy rats and indicated good metabolic stability with 41% of unchanged radioligand 1 h post injection and a limited crossing of the blood–brain barrier with a brain uptake of 0.02%ID/g 1 h post injection. In vivo PET imaging performed in the AAV- h P2Y 12 R rat model confirmed this low brain uptake, and no significant difference was found in the transfected (SUV mean 0.14 ± 0.01) versus contralateral (SUV mean 0.13 ± 0.01) striatum of the AAV- h P2Y 12 R model. Similar results were observed in healthy rats and in nonhuman primates. Additional studies in the presence of tariquidar led to a 3–4-fold increase in the [ 18 F] 41 brain concentration, suggesting that [ 18 F] 41 is a P-glycoprotein substrate. Future work will focus on improving radioligand design to enhance blood–brain barrier permeation and to reduce efflux transport.
No takes yet. Share an insight, caveat, or question.
Pincemail et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: